Michael Bumby
Direktor/Vorstandsmitglied bei MEDIPHARM LABS CORP.
Vermögen: 6 984 $ am 30.04.2024
Profil
Michael Bumby is the founder of Bluenose & Co. which was founded in 2013.
He is currently a Director at reBOOT Canada since 2013, a Director at MediPharm Labs Corp.
since 2023, and the Chief Financial Officer at Trimel Biopharma, Inc. since 2015.
Dr. Bumby's former jobs include being the Director-Finance & Investment Banking at Eli Lilly & Co. from 2000 to 2011, the Chief Financial Officer, Secretary & Director at VIVO Cannabis, Inc. in 2021, the Chief Financial Officer at Merus Labs, Inc., the Chief Financial Officer & Head-Investor Relations at Antibe Therapeutics, Inc. from 2013 to 2015, the Chief Financial Officer at Acerus Pharmaceuticals Corp.
from 2015 to 2016, the Chief Financial Officer & Investor Contact at Merus Labs International, Inc., and the Chief Financial Officer at Antibe Holdings, Inc. from 2012 to 2015.
Dr. Bumby's education includes a doctorate from the University of Guelph and an MBA from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDIPHARM LABS CORP.
0,03% | 22.12.2023 | 116 400 ( 0,03% ) | 6 984 $ | 30.04.2024 |
Aktive Positionen von Michael Bumby
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIPHARM LABS CORP. | Direktor/Vorstandsmitglied | 01.04.2023 |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Finanzdirektor/CFO | 03.08.2015 |
| reBOOT Canada | Direktor/Vorstandsmitglied | 01.09.2013 |
Ehemalige bekannte Positionen von Michael Bumby
| Unternehmen | Position | Ende |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Finanzdirektor/CFO | 01.06.2016 |
| ANTIBE THERAPEUTICS INC. | Finanzdirektor/CFO | 01.08.2015 |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Finanzdirektor/CFO | 01.07.2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.04.2011 |
Merus Labs, Inc.
 Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Finanzdirektor/CFO | - |
Ausbildung von Michael Bumby
| University of Guelph | Doctorate Degree |
| University of Toronto | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| MEDIPHARM LABS CORP. | Process Industries |
| Private Unternehmen | 8 |
|---|---|
Merus Labs, Inc.
Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Finance |
Trimel Biopharma, Inc.
Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Health Technology |
| reBOOT Canada | |
| Bluenose & Co. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries VIVO Cannabis, Inc. is a capital pool company, which engages in the production, sales, and research licenses from Health Canada; and operates indoor cultivation facilities. It operates through the following segments: Craft Cannabis Product, Medical Cannabis Clinic, and Corporate and International. The Craft Cannabis Product segment focuses on producing and selling cannabis and cannabis-derived products for direct sale to medical patient and for the adult-use market. The Medical Cannabis Clinic segment is involved and operated by its indirect wholly-owned subsidiary, Harvest Medicine Inc. The Corporate segment includes non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Toronto, Canada. | Process Industries |
